Brought to you by 
Cumberland Pharmaceuticals nets $79mm in IPO
21 Aug 2009
Executive Summary
Two years after filing, specialty pharmaco Cumberland Pharmaceuticals has completed its initial public offering, netting $79mm through the sale of 5mm shares at $17. (The company had originally planned to sell 6.25mm shares priced between $14 and $16 each, but last month in an amended S-1 filing it dropped the number of shares to 5mm and upped the target price to between $19 and $21.)
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cumberland Pharmaceuticals nets $79mm in IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice